pentetic acid has been researched along with Myasthenia Gravis in 2 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marienhagen, J | 1 |
Schalke, B | 1 |
Aebert, H | 1 |
Held, P | 1 |
Eilles, C | 1 |
Bogdahn, U | 1 |
Nordenbo, AM | 1 |
Somnier, FE | 1 |
2 other studies available for pentetic acid and Myasthenia Gravis
Article | Year |
---|---|
Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.
Topics: Female; Humans; Male; Middle Aged; Myasthenia Gravis; Octreotide; Pentetic Acid; Radiopharmaceutical | 1999 |
Acute deterioration of myasthenia gravis after intravenous administration of gadolinium-DTPA.
Topics: Acute Disease; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Male; Middle Aged; Myasthenia Gr | 1992 |